Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Keratin 17 is crucial for normal hair growth by regulating hair cycle transitions with TNFα.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

PCOS is linked to obesity and inflammation, increasing cardiovascular risk.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

High BMI worsens hair growth in women with PCOS.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

Breathing in high levels of certain air pollutants significantly increases women's risk of developing Polycystic Ovary Syndrome.

AMH is a promising biomarker for diagnosing PCOS.

PCOS is common in Brazilian women and linked to metabolic and reproductive issues.

Women with PCOS often have depression and anxiety, so they should be checked for these issues.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

COC treatment improves hormone and metabolic levels in PCOS patients.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.